|
Published by: Kalorama Information
Published: Apr. 1, 1998 - 320 Pages Now 25% off the original sale price of $3,250.
Table of Contents
Chapter One: Executive Summary
- Introduction to Cancer Diseases
- Overview
- Description of Cancer
- Tumor Development
- Current Treatment Options
- The Products
- Chemotherapeutic Agents
- Chemotherapeutic Adjuvants
- Biologic Agents
- Emerging Cancer Technologies
- Historical Background
- Cancer Prevalence, Incidence, and Frequency
- Geographic Incidence
- Most Common Cancers: Incidence, Prevalence, and Mortality
- Size of the Market
- Chemotherapeutic Agents
- Chemotherapeutic Adjuvants
- Biologic Agents
- Emerging Cancer Technogies
- Industry Participants
- Market Share
- Chemotherapeutic Agents
- Chemotherapeutic Adjuvants
- Biologic Agents
- Emerging Cancer Technologies
- Issues and Trends
- Pharmaceutical Company Merger and Acquisition Activity
- Managed Care
- Impact of Managed Care on Cancer Care
- Insurance Reimbursement
- Product Label Expansion and Patent Coverage Extension
- Scope and Methodology
Chapter Two: The Products
- Product Categories
- Industry Participants
- Pharmaceutical Companies
- Biotechnology Companies
- Chemotherapeutic Agents
- Alkylating/Alkaloid Agents
- Antibiotics
- Antimetabolites
- Hormones and Hormone Analogs
- Miscellaneous Antineoplastic Drugs
- Combinational Therapies
- Chemotherapeutic Adjuvants
- Antiemetic Agents
- Hypercalcemia Agents
- Myelosuppressive Agents
- Biologic Agents
- Interferons
- Interleukins
- Monoclonal Antibodies
- Nonadjuvant Growth Factors
- Emerging Cancer Technologies
- Antisense Nucleic Acids
- Chemoprotectants and Radioprotectants
- Gene Therapy
- Oncogenes and Tumor Suppressor Genes
- Photodynamic Therapy Compounds
- Vaccines
- Products Nearing the Market
Chapter Three: Issues And Trends
- Introduction
- Impact of Pharmaceutical Industry Changes
- Influence of Managed Care
- Driving Down Hospital Costs
- Geographic Concentration of Managed Care Hospitals
- Impact of Managed Care on Cancer Care
- Insurance Reimbursement
- Scandal and Backlash
- Funding and Investment Issues
- Cancers Receiving the Most Funding
- Private Funding
- Changing Investment Attitudes
- Collaborative Agreements
- Pharmaceutical Company Research and Development Spending
- Product Label Expansion and Patent Coverage Extension Issues
- Developments in Biotechnology
- Gene Therapies: The Future of the Cancer Therapeutics Market
- Chemotherapeutic Agents
Chapter Four: The Consumer
- The Cancer Patient
- Description of Cancer
- Tumor Development
- Causes of Mutation
- Historical Background
- Cancer Prevalence, Incidence, and Frequency
- Morbidity and Mortality
- Geographic Incidence
- Bladder Cancer
- Breast Cancer
- Colon and Rectal Cancers
- Hodgkin's Disease
- Kidney Cancer
- Leukemia
- Lung Cancer
- Non-Hodgkin's Lymphoma
- Oral Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Skin Cancer
- Stomach Cancer
- Uterine Cancer
- Current Cancer Treatment Options
- Antisense Nucleic Acids
- Bone Marrow Transplantation
- Chemotherapy
- Gene Therapy
- Hyperthermia
- Radiotherapy
- Surgery
- Targeted Drug Delivery
Chapter Five: The US Market
- Segmentation
- Methodology
- Size of the Market
- Sales and Forecast
- Market Trends
- Chemotherapeutic Agents
- Sales and Forecast
- Market Share
- Chemotherapeutic Adjuvants
- Sales and Forecast
- Market Share
- Biologic Cancer Agents
- Sales and Forecast
- Market Share
- Emerging Cancer Technologies
- Sales and Forecast
- Market Share
Chapter Six: Competitor Profiles
- Abbott Laboratories
- Agouron Pharmaceuticals, Inc
- American Home Products Corp
- Amgen Inc
- Bristol-Myers Squibb Co
- The Cancer Center: A New Managed Care Subsidiary
- Centocor, Inc
- Chiron Corp
- Novartis Corp
- Pasteur Mériux Connaught
- Genentech, Inc
- Hoffmann-La Roche Inc
- ImClone Systems, Inc
- Johnson & Johnson
- Eli Lilly and Co, Inc
- Pharmacia & Upjohn Co
- Schering-Plough Corp
- Zeneca Pharmaceuticals
Appendix A: Cancer Therapeutics
Appendix B: Company Names And Addresses
AbstractThis report details the scientific and market trends of the nearly $6 billion cancer therapeutics market. Learn about the impact of
cancer vaccines, cell cycle control, genetic therapies,
hematopoietic restoration, and other emerging technologies. Find
out about strategies companies are using to extend the life span of
brand-name cancer therapeutic products that are coming off
patent. Leading players are profiled. Individual sections are
available.
Get Full Details About This Report >>
|
